Skip to main content
Elsevier
View Cart

Migraine Management

  • 1st Edition, Volume 199 - February 1, 2024
  • Latest edition
  • Editors: Jerry W. Swanson, Manjit Matharu
  • Language: English

Migraine Management, Volume 199 covers the effective treatment of migraines, including different subtypes of migraines in different patient populations. The classific… Read more

World Book Day celebration

Where learning shapes lives

Up to 25% off trusted resources that support research, study, and discovery.

Explore resources

Description

Migraine Management, Volume 199 covers the effective treatment of migraines, including different subtypes of migraines in different patient populations. The classification and diagnostic criteria of common and uncommon subtypes of migraine is explored in detail, including childhood variants. An in-depth analysis of the pharmacology of acute and prophylactic agents is presented, along with an evidence-based review of pharmacologic management. This includes recently developed CGRP monoclonal antibodies and non-peptide small molecule CGRP antagonists. Advances in neuromodulatory treatments, both noninvasive and implantable are also critically reviewed.

Finally, specific treatment-related issues in pregnancy and lactation and childhood as well as the elderly are covered. Issues related to the diagnosis and management of vestibular migraine and the co-morbid disorder of persistent postural-perceptual dizziness are also explored.

Key features

  • Summarizes evidence-based best treatment for migraines
  • Differentiates treatment based on patient population, migraine type, and clinical setting
  • Includes pharmacological, biobehavioral, and physical treatments
  • Provides specialized treatments for children, the elderly, and pregnant patients

Readership

Clinical neurologists

Table of contents

Section I. Migraine Management

1. Non-specific analgesics, combination analgesics, and antiemetics

2. The 5-HT1B and 5-HT1D Agonists in Acute Migraine Therapy: Ergotamine, dihydroergotamine, and the triptans

3. 5-HT1F agonists

4. CGRP receptor antagonists (gepants)

5. Preventive treatment of migraine: Non-specific oral agents

6. OnabotulinumtoxinA: Discussion of the evidence for effectiveness of OnabotulinumA and its place in chronic migraine treatment

7. CGRP monoclonal antibodies and CGRP receptor antagonists (Gepants) in migraine prevention

8. Nutraceuticals in migraine

9. Interventional treatments

10. Biobehavioral treatments of migraine

11. Physical treatment of migraine

12. Neuromodulation in Migraine

Section II. Guidelines

13. Evidence-based symptomatic treatment of migraine

14. Evidence-based preventive treatment of migraine

Section III. Special Cases/Situations

15. Treatment in the emergency department

16. Special considerations in migraine during pregnancy and lactation

17. Special considerations in management of migraine in the elderly

18. Management of medication overuse headache

Section IV. Outcome Measures

19. Outcome Measures for Migraine: Measuring the impact of migraine and results of migraine treatment

Section V. Diagnosis and Treatment of Other Migraine Subtypes

20. Menstrually associated migraine

21. Hemiplegic migraine

22. Migraine with brainstem aura

23. Retinal migraine

24. Vestibular migraine and persistent postural perceptual dizziness

25. Status migrainosus

26. Persistent aura, visual snow, and other visual symptoms

27. Migrainous infarction

28. Migraine in children and adolescents: Assessment and Diagnosis

29. Management of migraine in children and adolescents

Section VI. Comorbidities of Migraine

30. Psychiatric Comorbidities of Migraine

31. Relationship of migraine and other forms of chronic pain

32. Comorbidities of Migraine: Sleep Disorders

33. The evolving concept of multimorbidity and migraine

Section VII. Future Directions

34. Healthcare disparities encountered by patients with headache disorders and potential strategies

35. Emerging and future directions of migraine research and treatment

Review quotes

*4 stars* "...covers evidence-based guidelines, special considerations, and diagnostic criteria of migraine subtypes, [and] the purpose is to be a clinical guide for practicing neurologists in all aspects of migraine management [which] is a worthy objective.....[W]ritten for healthcare practitioners, particularly neurologists or pain management specialists who treat the full spectrum of migraine disorders, [and] will help those specialists find the best treatment methods for these difficult cases....[C]onsiders migraine in specific populations such as elderly patients, children and adolescents, and pregnant patients. It explores different types of migraine — vestibular, retinal, hemiplegic – as well as future directions for migraine research. [A] quick reference, and the writing is succinct....[P]rovides a very comprehensive overview of migraine management, [and] can be read cover to cover or referenced on an as-needed basis."—©Doody’s Review Service, 2024, Adil F. Niaz, DO (Yale School of Medicine)

Product details

  • Edition: 1
  • Latest edition
  • Volume: 199
  • Published: March 12, 2024
  • Language: English

About the editors

JS

Jerry W. Swanson

Jerry W. Swanson, MD, is a consultant in the Department of Neurology and Professor of Neurology in the Mayo Clinic College of Medicine and Science. Dr. Swanson received his medical degree from the Feinberg School of Medicine at Northwestern University in Chicago. He completed a neurology residency at Mayo Clinic. He earned the Master of Health Professions degree at the University of Illinois at Chicago. He has been on the staff of Mayo Clinic in Rochester, Minn., since 1982. He is former chair of the Headache Division in the Department of Neurology and founding director of the headache medicine fellowship at Mayo Clinic in Minnesota. Dr. Swanson is board-certified in Neurology and in the subspecialty of Headache Medicine. He has written extensively about headache and other neurologic disorders. Swanson has made more than 100 presentations at national and international meetings, published more than 60 peer-reviewed articles, and numerous book chapters; he is an associate editor for the journal Headache and is a neurology editor for MayoClinic.com, a leading site for health information for the public. He has co-edited two books including The Mayo Clinic on Headache, a highly praised book for the lay public. He is a neurology editor for MayoClinic.com and is the headache topic editor and neurology editor-in-chief for UpToDate. He was a founding member for the UCNS Headache Medicine examination committee and is currently serving another term on the committee. He was the founding director of the Headache Medicine fellowship at Mayo Clinic in Rochester, Minn. Dr. Swanson has served in several leadership roles in the American Academy of Neurology and the American Headache Society and was a member of the International Headache Congress scientific program committee. He has been the recipient of the Mayo Medical School Dean’s Recognition Award.
Affiliations and expertise
Mayo Clinic College of Medicine and Science, Rochester, MN, United States

MM

Manjit Matharu

Dr. Manjit Matharu is a Consultant Neurologist at the National Hospital for Neurology and Neurosurgery, Queen Square, London. He received a BSc (First Class Honours) University of Manchester and MB, ChB (Honours Degree) University of Manchester. He earned a PhD at the University of London. He completed his residency in Neurology at The National Hospital for Neurology and Neurosurgery, The Royal London Hospital and Homerton Hospital in London in 2007. Dr Matharu’s major research interests include functional and structural imaging in Primary headaches, trigeminal autonomic cephalalgias and neurostimulation for intractable headaches. He has authored over 100 scientific papers. Dr. Matharu is the clinical and academic lead of the Headache Group at The National Hospital for Neurology and Neurosurgery, which is widely recognized as one of the foremost Headache Centers worldwide. He has lectured on headache topics both domestically and internationally.
Affiliations and expertise
Consultant Neurologist, National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom

View book on ScienceDirect

Read Migraine Management on ScienceDirect